Loading...
Keywords
Last Name
Institution

Jonathan Wagner

Concepts (134)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
7
2022
22
3.600
Why?
Hypercholesterolemia
3
2020
10
2.160
Why?
Pravastatin
3
2020
7
2.060
Why?
Humans
24
2023
6332
0.990
Why?
Child
18
2023
3117
0.970
Why?
Simvastatin
2
2019
10
0.840
Why?
Genetic Variation
3
2019
143
0.790
Why?
Male
13
2023
3225
0.770
Why?
Rosuvastatin Calcium
1
2020
5
0.760
Why?
Pharmacogenetics
4
2022
153
0.750
Why?
Hydroxymethylglutaryl CoA Reductases
1
2019
1
0.720
Why?
Cardiac Surgical Procedures
2
2016
25
0.700
Why?
Dose-Response Relationship, Drug
4
2020
91
0.630
Why?
CHARGE Syndrome
1
2017
1
0.630
Why?
Aortic Coarctation
1
2017
6
0.620
Why?
Adolescent
9
2023
2067
0.610
Why?
Abnormalities, Multiple
1
2017
38
0.600
Why?
Myxoma
1
2016
1
0.590
Why?
Heart Neoplasms
1
2016
2
0.590
Why?
Lactones
1
2016
3
0.580
Why?
Chromatography, High Pressure Liquid
1
2016
39
0.570
Why?
Tandem Mass Spectrometry
1
2016
19
0.570
Why?
Arrhythmogenic Right Ventricular Dysplasia
2
2013
3
0.560
Why?
Warfarin
1
2015
12
0.550
Why?
Oseltamivir
1
2015
6
0.550
Why?
Anticoagulants
1
2015
14
0.540
Why?
Hypoplastic Left Heart Syndrome
1
2015
20
0.540
Why?
Antiviral Agents
1
2015
27
0.540
Why?
Oxygen Consumption
3
2023
14
0.520
Why?
Female
8
2023
3348
0.510
Why?
Pharmacokinetics
1
2013
15
0.470
Why?
Pharmaceutical Preparations
1
2013
37
0.460
Why?
Cholesterol, LDL
1
2012
6
0.450
Why?
Dyslipidemias
1
2012
14
0.450
Why?
Angina Pectoris
1
2012
1
0.440
Why?
Troponin
1
2012
1
0.440
Why?
Sulfonamides
2
2023
6
0.430
Why?
Non-alcoholic Fatty Liver Disease
2
2021
22
0.400
Why?
Young Adult
4
2023
620
0.380
Why?
Exercise Test
3
2023
13
0.330
Why?
Pediatric Obesity
2
2021
124
0.320
Why?
Child Development
2
2019
42
0.290
Why?
Echocardiography
3
2016
61
0.280
Why?
Magnetic Resonance Imaging, Cine
2
2016
4
0.260
Why?
Pyrimidines
2
2023
5
0.250
Why?
Age Factors
3
2021
212
0.250
Why?
Pediatrics
2
2019
175
0.240
Why?
Hyperlipidemias
2
2019
7
0.210
Why?
End Stage Liver Disease
1
2021
2
0.200
Why?
Syncope
1
2021
1
0.200
Why?
Adult
4
2023
1152
0.200
Why?
Life Style
1
2021
33
0.200
Why?
Heart Ventricles
2
2023
38
0.200
Why?
Weight Loss
1
2021
39
0.200
Why?
Inhibitory Concentration 50
1
2020
5
0.200
Why?
Stereoisomerism
1
2020
9
0.200
Why?
Mutagenesis, Site-Directed
1
2020
14
0.200
Why?
Patient Selection
1
2021
41
0.200
Why?
Hydrogen-Ion Concentration
1
2020
20
0.200
Why?
HEK293 Cells
1
2020
29
0.200
Why?
Genotype
2
2019
316
0.190
Why?
Phosphodiesterase 5 Inhibitors
1
2019
2
0.190
Why?
Obesity
1
2021
125
0.190
Why?
Diagnosis, Differential
3
2021
79
0.190
Why?
Heart Diseases
1
2019
14
0.190
Why?
Drug Dosage Calculations
1
2019
17
0.180
Why?
Drug Prescriptions
1
2019
22
0.180
Why?
Thrombosis
2
2019
12
0.180
Why?
Medication Therapy Management
1
2019
7
0.180
Why?
Drug Delivery Systems
1
2019
5
0.180
Why?
Models, Biological
1
2019
44
0.180
Why?
Genetic Association Studies
1
2019
31
0.180
Why?
Polymorphism, Single Nucleotide
1
2020
211
0.170
Why?
Precision Medicine
1
2019
43
0.170
Why?
Treatment Outcome
2
2019
641
0.170
Why?
Heart Defects, Congenital
2
2021
75
0.160
Why?
Polymorphism, Genetic
1
2018
81
0.160
Why?
Disease Progression
2
2021
98
0.160
Why?
Aortography
1
2017
2
0.160
Why?
Research Design
2
2019
63
0.150
Why?
Infant, Newborn
2
2017
811
0.150
Why?
Isomerism
1
2016
2
0.140
Why?
Linear Models
1
2016
55
0.140
Why?
Electrocardiography
2
2013
10
0.140
Why?
International Normalized Ratio
1
2015
4
0.140
Why?
Sensitivity and Specificity
1
2016
140
0.140
Why?
Reproducibility of Results
1
2016
180
0.140
Why?
Drug Interactions
1
2015
29
0.140
Why?
Genetic Testing
2
2013
78
0.130
Why?
Influenza, Human
1
2015
51
0.130
Why?
Ultrasonography, Doppler, Transcranial
1
2014
3
0.130
Why?
Cerebrovascular Circulation
1
2014
2
0.130
Why?
Embolization, Therapeutic
1
2014
12
0.130
Why?
Biological Availability
1
2013
7
0.120
Why?
Half-Life
1
2013
10
0.120
Why?
Absorption
1
2013
7
0.120
Why?
Tissue Distribution
1
2013
11
0.120
Why?
Long QT Syndrome
1
2013
3
0.120
Why?
Myocardium
1
2012
9
0.110
Why?
Biopsy
1
2012
57
0.110
Why?
Biomarkers
1
2012
112
0.110
Why?
Exercise
2
2023
119
0.100
Why?
Exercise Tolerance
1
2023
4
0.060
Why?
Haplotypes
1
2022
63
0.050
Why?
Cross-Sectional Studies
1
2023
301
0.050
Why?
Cytochrome P-450 Enzyme System
1
2022
86
0.050
Why?
Alleles
1
2022
164
0.050
Why?
Unconsciousness
1
2021
1
0.050
Why?
Syncope, Vasovagal
1
2021
1
0.050
Why?
Arrhythmias, Cardiac
1
2021
2
0.050
Why?
Cardiomyopathies
1
2021
6
0.050
Why?
Hypertension, Pulmonary
1
2021
9
0.050
Why?
Clinical Trials as Topic
1
2021
42
0.050
Why?
Seizures
1
2021
25
0.050
Why?
Prognosis
1
2021
181
0.050
Why?
Placebo Effect
1
2019
1
0.050
Why?
Natriuretic Peptide, Brain
1
2019
5
0.050
Why?
Double-Blind Method
1
2019
49
0.050
Why?
Heart Rate
1
2019
24
0.050
Why?
Fontan Procedure
1
2019
14
0.050
Why?
Drug Administration Schedule
1
2019
41
0.050
Why?
Risk Factors
1
2021
409
0.050
Why?
Comorbidity
1
2019
63
0.050
Why?
Molecular Targeted Therapy
1
2019
11
0.040
Why?
Cytochrome P-450 CYP3A
1
2019
45
0.040
Why?
Child, Preschool
1
2021
1480
0.040
Why?
Cognition
1
2014
30
0.030
Why?
Catheter Ablation
1
2013
2
0.030
Why?
Adrenergic beta-Antagonists
1
2013
4
0.030
Why?
Cardiac Catheterization
1
2013
17
0.030
Why?
Follow-Up Studies
1
2014
308
0.030
Why?
Magnetic Resonance Imaging
1
2013
112
0.030
Why?
Mutation
1
2013
181
0.030
Why?
Infant
1
2014
1409
0.020
Why?
Wagner's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_